1. Home
  2. BWAY vs LEGT Comparison

BWAY vs LEGT Comparison

Compare BWAY & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • LEGT
  • Stock Information
  • Founded
  • BWAY 2003
  • LEGT 2023
  • Country
  • BWAY Israel
  • LEGT United States
  • Employees
  • BWAY N/A
  • LEGT N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • LEGT
  • Sector
  • BWAY Health Care
  • LEGT
  • Exchange
  • BWAY Nasdaq
  • LEGT Nasdaq
  • Market Cap
  • BWAY 280.7M
  • LEGT 277.1M
  • IPO Year
  • BWAY 2019
  • LEGT 2024
  • Fundamental
  • Price
  • BWAY $14.97
  • LEGT $10.74
  • Analyst Decision
  • BWAY Strong Buy
  • LEGT
  • Analyst Count
  • BWAY 2
  • LEGT 0
  • Target Price
  • BWAY $18.00
  • LEGT N/A
  • AVG Volume (30 Days)
  • BWAY 61.1K
  • LEGT 17.9K
  • Earning Date
  • BWAY 11-11-2025
  • LEGT 01-01-0001
  • Dividend Yield
  • BWAY N/A
  • LEGT N/A
  • EPS Growth
  • BWAY 679.98
  • LEGT N/A
  • EPS
  • BWAY 0.11
  • LEGT 0.35
  • Revenue
  • BWAY $46,084,000.00
  • LEGT N/A
  • Revenue This Year
  • BWAY $335.63
  • LEGT N/A
  • Revenue Next Year
  • BWAY $22.10
  • LEGT N/A
  • P/E Ratio
  • BWAY $55.30
  • LEGT $30.60
  • Revenue Growth
  • BWAY 26.50
  • LEGT N/A
  • 52 Week Low
  • BWAY $7.84
  • LEGT $10.18
  • 52 Week High
  • BWAY $17.00
  • LEGT $10.86
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 48.22
  • LEGT 50.70
  • Support Level
  • BWAY $14.65
  • LEGT $10.72
  • Resistance Level
  • BWAY $15.60
  • LEGT $10.74
  • Average True Range (ATR)
  • BWAY 0.67
  • LEGT 0.01
  • MACD
  • BWAY -0.11
  • LEGT -0.00
  • Stochastic Oscillator
  • BWAY 29.79
  • LEGT 33.33

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About LEGT Legato Merger Corp. III

Legato Merger Corp III is a blank check company.

Share on Social Networks: